HALO
Halozyme Therape (HALO)
NASDAQ
$100.95-$0.74 (-0.72%)
Price as of Nov 12, 2026 9:35 AM EST
  • $11.6B
    Market Cap
  • 43.96%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 62
Valuation
HALO
vs History
vs S&P 500
Profitability
0
Growth
-0
Low Earnings Volatility
1

Momentum Score

Score: 83
Valuation
HALO
vs History
vs S&P 500
3-Month Momentum
6.82%
12-Month Momentum
56.31%
3-Month Risk Adjusted Momentum
60.22%
12-Month Risk Adjusted Momentum
155.07%

True Yield

N/A
Valuation
HALO
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
3.53%
Net Debt Paydown Yield
-12.44%

Financial Health Score

Score: 52
Valuation
HALO
vs History
vs S&P 500
Ohlson's O-Score
6